Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ángel Miracle Blanco"'
Autor:
Belén Arroyo Rivera, Hugo del Castillo, José Manuel Rubio Campal, Mikel Taibo Urquia, José Tuñón Fernández, Ángel Miracle Blanco, Loreto Bravo Calero, Pepa Sánchez Borque, Carmen de Juan Bitriá, David Martí Sánchez
Publikováno v:
Cardiol J
Background: Clinical management of cardiac resynchronization therapy (CRT) non-responders is difficult, and their prognosis is poor. The aim of the present study was to evaluate whether treatment with sacubitril/valsartan can improve quality of life
Publikováno v:
Journal of Electrocardiology. 62:26-29
A 44-year-old woman with a past history of surgical ablation of an accessory pathway presented to our facility with episodes of palpitations and dizziness. An ECG showed sinus rhythm with a prolonged PR interval and a preexcited QRS complex. An EP st
Publikováno v:
Journal of Electrocardiology. 61:133-136
Autor:
Ricardo Salgado-Aranda, Adolfo Fontenla, Miguel A. Arias, Ángel Miracle-Blanco, Elena Mejía-Martínez, Juan Tamargo-Menéndez, Juan Ramón Rey-Blas, Agustín Pastor-Fuentes, Isabel Montilla, Roberto Matía-Francés, María López-Gil, Agustín Gómez de la Cámara, Jorge Toquero-Ramos, Fernando Arribas
Publikováno v:
Revista Española de Cardiología. 73:368-375
Resumen Introduccion y objetivos La ivabradina es un inhibidor de la corriente If, principal determinante de la funcion marcapasos del nodulo sinusal, aprobado como antianginoso y para tratar la insuficiencia cardiaca. Existen indicios sobre su capac
Autor:
Ángel Miracle-Blanco, Fernando Arribas, Adolfo Fontenla, Ricardo Salgado-Aranda, Jorge Toquero-Ramos, Isabel Montilla, Juan Tamargo-Menéndez, Miguel A. Arias, Juan Ramón Rey-Blas, Agustín Pastor-Fuentes, Roberto Matía-Francés, Brake-Af investigators, Elena Mejía-Martínez, María López-Gil, Agustín Gómez de la Cámara
Publikováno v:
Revista Española de Cardiología (English Edition). 73:368-375
Introduction and objectives Ivabradine is an inhibitor of the If channel, the main determinant of the pacemaker function of the sinus node. The drug has been approved for the treatment of angina and heart failure. There is some evidence of its role a
Autor:
Julian Crosa, José Tuñón Fernández, Ángel Miracle Blanco, Loreto Bravo Calero, Pepa Sánchez Borque, José Manuel Rubio Campal
Publikováno v:
Pacing and Clinical Electrophysiology. 43:62-67
Background Superior vena cava (SVC) isolation with radiofrequency energy remains a challenge due to potential side effects, especially phrenic nerve (PN) or sinus node injury. The purpose of this study was to evaluate the feasibility of a novel SVC i
Autor:
Ángel Miracle Blanco, José Tuñón Fernández, Carla Lázaro Rivera, Camila Sofía García-Talavera, Loreto Bravo Calero, Abel Castellanos Olmedilla, José Manuel Rubio Campal
Publikováno v:
The American journal of cardiology. 161
Management of asymptomatic subjects with preexcitation remains controversial. Our objective was to analyze the reasons an electrophysiological study (EPS) was performed in an asymptomatic population referred for the procedure, and compare the results
Autor:
José María Serratosa Fernández, José Tuñón Fernández, Loreto Bravo Calero, Pepa Sánchez Borque, Rafael Sáez Pinel, Ángel Miracle Blanco, Ivana Zamarbide Capdepón, Inmaculada Navas Vinagre, M Araceli García Torres, José Manuel Rubio Campal
Publikováno v:
The American journal of cardiology. 125(3)
Atrial fibrillation (AF) causes a substantial proportion of embolic strokes of undeterminded source (ESUS). Effective detection of subclinical AF (SCAF) has important therapeutic implications. We conducted a prospective study to determine the prevale
Autor:
Ángel Miracle Blanco, Julian Crosa, José Manuel Rubio Campal, Juan Benezet-Mazuecos, Pepa Sánchez Borque
Publikováno v:
Journal of electrocardiology. 53
Autor:
José Manuel Rubio Campal, Juan Benezet-Mazuecos, Julian Crosa, P. Sánchez-Borque, Miguel A. Arias, Ángel Miracle Blanco
Publikováno v:
Journal of electrocardiology. 51(6)
We report on a case of a 78-years-old patient with a subcutaneous implantable cardioverter defibrillator (S-ICD) and an episode of a sustained ventricular tachycardia (VT) at a rate slower than the programmed shock zone. Because of T-wave oversensing